Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-19-007880

SVP & Chief Accounting Officer sold 16,119 shares at $42.16 ($679,577)

  • SVP & Chief Accounting Officer acquired 16,119 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Thomsen Jillian B. SVP & Chief Accounting Officer 2019-02-04 Option exercise +16,119 $10.69 $172,312 184,318 D: show line 1 in the form
Thomsen Jillian B. SVP & Chief Accounting Officer 2019-02-04 Sale −16,119 $42.16 $679,577 168,199 D: show line 2 in the form
Open-market sales · 16,119 sh · avg $42.16 · $679,577

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Thomsen Jillian B. SVP & Chief Accounting Officer 2019-02-04 Option exercise · Stock Option −16,119 0 D: show line 3 in the form
Loading xslF345X03/doc4.xml…